Transforming drug, med-tech R&D with AI
Published August 2019
Deals analysis
Transforming R&D and health care with artificial intelligence
Biopharmas move into deep waters of massive data, high R&D potential
AI propels med tech into new partnerships, new possibilities
Global regulatory impacts
U.S. AI med-tech regs in development ‘not for the faint of heart’
The scientific black box – changing skillsets – intellectual property
AI’s superpowers lie in questions, not answers
Across the great (skills) divide
Supreme Court’s Alice decision leaves drug, device firms in AI wonderland
Research hospitals push AI beyond pattern recognition
Follow the money
What if artificial intelligence invents something?
Digital health financings sees continued momentum
VC meeting at the crossroads of biopharma R&D, computation
Clinical trials integration
AI starting to improve efficiency in med-tech clinical trials
AI in the clinic opens new vistas for biopharma investigators
AI in Asia-Pacific
AI is expected to drive health care effectiveness, increase jobs in Australia